Works matching IS 0008543X AND DT 2023 AND VI 129 AND IP 8


Results: 20
    1
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE‐158 study.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 8, p. 1195, doi. 10.1002/cncr.34657
    By:
    • Oh, Do‐Youn;
    • Algazi, Alain;
    • Capdevila, Jaume;
    • Longo, Federico;
    • Miller, Wilson;
    • Chun Bing, Jerry Tan;
    • Bonilla, Carlos Eduardo;
    • Chung, Hyun Cheol;
    • Guren, Tormod K.;
    • Lin, Chia‐Chi;
    • Motola‐Kuba, Daniel;
    • Shah, Manisha;
    • Hadoux, Julien;
    • Yao, Lili;
    • Jin, Fan;
    • Norwood, Kevin;
    • Lebellec, Loïc
    Publication type:
    Article
    13
    14

    Issue Information.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 8, p. 1133, doi. 10.1002/cncr.33707
    Publication type:
    Article
    15
    16
    17
    18
    19
    20